Inclusion Criteria:

* Patients with suspected ovarian, fallopian tube, primary peritoneal carcinomas or advanced stage papillary serous uterine carcinoma irrespective of performance status; this clinical determination is made by the treating physician
* Patients must have signed an approved informed consent and authorization permitting release of personal health information
* Patients who can understand sufficiently to be able to respond to questions posed by the study instruments
* Patients and/or caregiver (durable power of attorney) can give consent and caregiver can assist with the responses to questionnaire

* NOTE: it is the intent of this trial that all patients 70 years or older presenting to the participating physician/center be offered enrollment onto this study; eligible patients may enroll and subsequently receive neoadjuvant chemotherapy followed by interval surgery, primary cytoreductive surgery or no surgery at all
* Post-operative pathology will not exclude patients from this study

Exclusion Criteria:

* Patients whose circumstances at the time of study entry do not permit completion of the study or required follow-up
* Patients who would have planned surgery performed by the minimally invasive technique; institutions which perform cytoreductive surgery via the minimally invasive technique should not participate in this study; the minimally invasive surgery (MIS) technique is also not considered standard technique for primary cytoreductive surgery for advanced stage ovarian, fallopian tube or peritoneal cancers
* Patients who receive chemotherapy treatment (for a gynecologic malignancy) prior to consideration of enrollment into this trial and taking the geriatric assessment will be excluded
* Patients who have a known pre-operative primary uterine cancer, confirmed by endometrial biopsy